ENDRA Life Sciences Inc. NDRA
Set alert
4.75 USD -0.13 -2.66%
At close · Oct 30
4.51 -0.24 -5.05%
After hours · Oct 30, 4:00 PM ET
4.72 Day range 4.86
3.26 52-week range 6.70
- YTD
- +4.86%
- 1 year
- -2.66%
- Open
- 4.85
- Prev close
- 4.88
- Mkt cap
- 7.12M
- Vol
- 10.57K
- Avg vol
- 31.27K
- EPS
- -6.26
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 4.72
- High
- 4.86
- Forward P/E
- -0.02
- Beta
- 0.74
- Short ratio
- 0.05
- Inst. own
- 0.49%
- Dividend
- 0.00
- Ex-div date
- 50-d avg
- 6.68
- 200-d avg
- 291.96
- 1y target
- 2,625.00
5D chart
Signals (26)
| Name | Time | Ago |
|---|---|---|
| MACD: Sell Signal | Oct 29, 4:00 PM | 2 days ago |
| SMA: Bearish | Oct 29, 3:55 PM | 2 days ago |
| SMA: Bullish | Oct 29, 3:10 PM | 2 days ago |
| SMA: Bullish | Oct 29, 3:10 PM | 2 days ago |
| SMA: Bearish | Oct 29, 1:25 PM | 2 days ago |
| SMA: Bearish | Oct 29, 1:25 PM | 2 days ago |
| SMA: Bullish | Oct 29, 11:50 AM | 3 days ago |
| SMA: Bullish | Oct 29, 11:50 AM | 3 days ago |
| MACD: Buy Signal | Oct 29, 11:50 AM | 3 days ago |
| MACD: Sell Signal | Oct 29, 11:10 AM | 3 days ago |
| SMA: Bearish | Oct 29, 10:05 AM | 3 days ago |
| SMA: Bearish | Oct 29, 10:05 AM | 3 days ago |
| MACD: Buy Signal | Oct 29, 9:55 AM | 3 days ago |
| SMA: Bullish | Oct 29, 9:50 AM | 3 days ago |
| SMA: Bearish | Oct 28, 1:20 PM | 3 days ago |
| SMA: Bearish | Oct 28, 1:20 PM | 3 days ago |
| MACD: Sell Signal | Oct 28, 1:20 PM | 3 days ago |
| SMA: Bullish | Oct 28, 11:20 AM | 4 days ago |
| SMA: Bearish | Oct 28, 10:20 AM | 4 days ago |
| SMA: Bullish | Oct 27, 3:05 PM | 4 days ago |
| SMA: Bullish | Oct 27, 3:05 PM | 4 days ago |
| SMA: Bearish | Oct 27, 2:40 PM | 4 days ago |
| SMA: Bullish | Oct 27, 2:20 PM | 4 days ago |
| RSI: Overbought | Oct 26, 12:25 PM | 5 days ago |
| SMA: Bullish | Oct 26, 11:00 AM | 6 days ago |
| SMA: Bearish | Oct 26, 10:45 AM | 6 days ago |
Financial health
Altman Z-Score
-19.47 Distress zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
2 / 9 Weak
Nine pass/fail tests of profitability, leverage and efficiency.
FMP rating
C+2 / 5 overall
- DCF 2
- Return on Equity 1
- Return on Assets 1
- Debt / Equity 3
- P/E 1
- P/B 4
Valuation
P/E -0.5×
FY 2016 5y median -630× FY 2025
P/S 0.0×
FY 2016 5y median 0.0× FY 2025
P/B 1.6×
FY 2016 5y median 1120× FY 2025
P/FCF -0.7×
FY 2016 5y median -661× FY 2025
EV/EBITDA -0.5×
FY 2016 5y median -647× FY 2025
EV/Sales 0.0×
FY 2016 5y median 0.0× FY 2025
FCF Yield -145.8%
FY 2016 5y median -0.2% FY 2025
Profitability
Gross Margin 0.0%
FY 2016 5y median 0.0% FY 2025
Operating Margin 0.0%
FY 2016 5y median 0.0% FY 2025
Net Margin 0.0%
FY 2016 5y median 0.0% FY 2025
ROE -310.9%
FY 2016 5y median -182.9% FY 2025
ROIC -178.3%
FY 2016 5y median -173.8% FY 2025
ROA -182.4%
FY 2016 5y median -148.9% FY 2025
Growth (YoY)
Revenue 0.0%
FY 2016 FY 2025
Operating Income 46.7%
FY 2016 FY 2025
EPS (diluted) 12.9%
FY 2016 FY 2025
Free Cash Flow 29.9%
FY 2016 FY 2025
Financial Health
Current Ratio 1.3×
FY 2016 5y median 5.0× FY 2025
Quick Ratio 1.3×
FY 2016 5y median 3.5× FY 2025
Debt / Equity 0.2×
FY 2016 5y median 0.1× FY 2025
Net Debt / EBITDA 0.0×
FY 2016 5y median 0.2× FY 2025
Interest Coverage 0.0×
FY 2016 5y median 0.0× FY 2025
Dividends
Dividend Yield 0.0%
FY 2016 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2016 5y median -0.0% FY 2025
Annual · latest fiscal year ends 2025-12-31